m10zh09 vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01405521)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Salmonella typhiImmunity, active
Salmonella typhi immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- m10zh09 vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01405521 | Phase 2 | Dec 1, 2011 | University of London, University of Maryland, University of Oxford, Wellcome Trust |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of London | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Maryland | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2011 |
4 organizations
Page 1 / 1